No Detail Found!

High sensitivity crp in female patients with ischemic stroke, epilepsy, post-stroke epilepsy and ischemic heart disease

Author(s)
Samir Mohammed Abdulfattah Attia University Medical Centre (UMC), Umm Al-Qura University,Makkah, Ministry of Health,Saudi Arabia
Yaser Hasan Bahakeem University Medical Centre (UMC), Umm Al-Qura University,Makkah, Ministry of Health,Saudi Arabia
Abdulhalim S. Serafi Department of Physiology, Faculty of Medicine, Umm Al-Qura University,Makkah,Saudi Arabia
Zahir Hussain University Medical Centre (UMC), Umm Al-Qura University, Makkah, Ministry of Health, Saudi Arabia; Department of Physiology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia
Gisela H. Maia EEG Department, Medibrain-Center for Neurophysiology Studies, Neurofeedback Therapy & Brain Research Institute,Porto,Portugal
M.H. Hussain Biomedical, Computational and Theoretical Research (BCTR) Lab,Karachi,Pakistan
Mohammed A. Bafail Department of Physiology, Faculty of Medicine, Umm Al-Qura University,Makkah,Saudi Arabia
Abstract
Estimation of C-reactive protein (CRP) is widely considered for investigating the degree of inflammation especially in coronary heart disease (CHD) and ischemic stroke (IS). A variety of studies have been conducted. However, precise correlation of age-related hs-CRP levels with the severity of injury is not known. Hence, we carried out present study in age-matched (age range 55-66 years) female patients of ischemic stroke (IS), epilepsy (E), post-ischemic stroke epilepsy (pIS-E) and ischemic heart disease (IHD) and compared with the normal female control subjects (C). Group comparisons showed significant variations of hs-CRP (mg/L) for IS vs. C, E vs. C, pIS-E vs. C, IHD vs. C, IHD vs. E, E vs. IS and IHD vs. pIS-E and non-significant change for pIS-E vs. IS, IHD vs. IS and pIS-E vs. E, that revealed the role inflammation via change in hs-CRP not only in patients with ischemic disorders but also in epilepsy patients though the extent of increase in hs-CRP was quite less in epilepsy patients. Moreover, significant positive correlation of age and hs-CRP levels was revealed for the mentioned female patients with ischemic disorders and epilepsy. Conclusively, we investigated the role and involvement of hs-CRP in female patients with ischemic stroke, ischemic heart disease and post-ischemic stroke epilepsy and also in patients with epilepsy without apparent involvement of ischemic complications. Hence, inflammation seems a major factor causing atherosclerotic conditions in neurovascular and cardiovascular disorders.
Publication Details
Page(s) 445-453
DOI DOI not available
Published Journal: International Journal of Biology and Biotechnology, Volume: 17, Issue: 3, Year: 2020

Request the full text from PASTIC

Keywords
Ischemic Stroke, post-ischemic stroke epilepsy, Ischemic Heart Disease, hs-CRP, Age, Epilepsy, inflammation
References
Åberg N.D.,Wall A.,Anger O.,Jood K.,Andreasson U.,Blennow K.,Zetterberg H.,Isgaard J.,Jern C.,Svensson C. .2020 .Circulating levels of vascular endothelial growth factor and post-stroke long-term functional outcome. Acta Neurol Scand, 141(5) : 405-414.
Ahmadi S.,Achari V.M.,Hussain Z.,Hashim R. .2017 .Epimeric and anomeric relationship of octyl- α -Dgluco/galactosides: insight from density functional theory and atom in molecules studies. Computational and Theoretical Chemistry, 1108 : 93-102.
Bos C.M.,Schipper P.J.,Koudstaal J.C.,Witteman A.,Hofman and M.M.Breteler A. .2006 .High serum Creactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation, 114(15) : 1591-1598.
Bouzidi N.,M.B. Messaoud F.,Maatouk H.,Gamra S.,Ferchichi S. .2020 .Relationship between high sensitivity C-reactive protein and angiographic severity of coronary artery disease. Journal of Geriatric Cardiology : JGC, 17(5) : 256-263.
Chambers J. C.,Eda S.,Bassett P.,Karim Y.,Thompson S.G.,Gallimore J.R.,Pepys M.B.,Kooner J.S. .2001 .C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation, 104(2) : 145-150.
Chen N. C.,Chen C.H.,Lin T.K.,Chen S.D.,Tsai M.H.,Chang C.C.,Tsai W.C.,Chuang Y.C. .2018 .Risk of Microangiopathy in Patients with Epilepsy under Long-term Antiepileptic Drug Therapy. , 9 : 113.
Danesh J.,Wheeler J.C.,Hirschfield G.M.,Eda S.,Eiriksdottir G.,Rumley A.,Lowe G.D.,Pepys M.B.,Gudnason V. .2004 .C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. The New England Journal of Medicine, 350(14) : 1387-1397.
Napoli Di,M. Di,Slevin M.,Popa-Wagner A.,Singh P.,Lattanzi S.,Divani A.A. .1921 .Monomeric C-Reactive Protein and Cerebral Hemorrhage: From Bench to Bedside. , 9 : .
Gabay C.,I. Kushner C. .1999 .Acute-phase proteins and other systemic responses to inflammation. The New England Journal of Medicine, 340(6) : 448-454.
Danesh J.,Wheeler J.C.,Hirschfield G.M.,Eda S.,Eiriksdottir G.,Rumley A.,Lowe G.D.,Pepys M.B.,Gudnason V. .2004 .C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. The New England Journal of Medicine, 350(14) : 1387-1397.
Gao W.,J. Wu J.,Wei L.,Pu C.,Guo J.,Yang M.,Yang H.,Luo H. .2014 .Brazilian green propolis improves immune function in aged mice. Journal of Clinical Biochemistry and Nutrition, 55(1) : 7-10.
Golukhova E. Z.,Grigoryan M.V.,Ryabinina M.N.,N.I. Bulaeva M.N. .2018 .High On-Treatment Platelet Reactivity Determinants on Dual Antiplatelet Therapy in Patients With Ischemic Heart Disease Before Elective Percutaneous Coronary Intervention. , 58(4) : 5-14.
Gong P.,Huang T.,Chen W.,Jiang T.,Gong Y.,Lu M.,Wang M.,Zhang Y.,Zhang X.,Deng Q.,Zhou Q. .2019 .The association between high-sensitivity C-reactive protein at admission and progressive motor deficits in patients with penetrating artery infarctions. BMC Neurology, 19(1) : 346.
Harutyunyan M. J.,Mathiasen A.B.,Winkel P.,Gøtze J.P.,Hansen J.F.,Hildebrandt P.,Jensen G.B.,Hilden J.,Jespersen C.M.,Kolmos H.J.,Gluud C.,Kastrup J. .2011 .Highsensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial. Scandinavian Journal of Clinical and Laboratory Investigation, 71(1) : 52-62.
Hussain Z. .2010 .Germany (Printed in USA. Menstrual Cycle and Epilepsy: Premenstrual Reproductive Study. 1st Edn, 239 : .
Hussain Z.,Sohail S.,Ashraf A .2007 .Endothelial dysfunction, cytokines and diabetes mellitus. Hum Health, 3(7) : 3-4.
Hussain Z. .1991 .Clinicobiological study of coronary artery disease. Pak Med, 14(5) : 35-38.
Kes V. B.,M.J. Jurašić M.,Lisak V.,Jelec L.Z.,Matovina L.Z. .2016 .Age and gender differences in acute stroke hospital patients. Acta Clinica Croatica, 55(1) : 69-78.
Khera A.,J.A. de Lemos R.M.,Peshock H.S.,Lo H.G.,Stanek S.A.,Murphy F.H.,Jr. Wians S.M.,Grundy S.M.,D.K. McGuire S.M. .2006 .Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation, 113(1) : 38-43.
Kincl V.,Panovsky R.,Meluzin J.,Semenka J.,Groch L.,Tomcikova D.,Jarkovsky J.,Dusek J. .2010 .Association between laboratory markers and presence of coronary artery disease. Biomedical Papers of the Medical Faculty of the University Palacky. , 154(3) : 227-233.
Koc M.,Karaarslan O.,Abali and M.K. Batur G. .2010 .Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease. Texas Heart Institute Journal, 37(1) : 42-48.
Koenig W.,Sund M.,Fröhlich M.,Fischer H.G.,Löwel H.,Döring A.,Hutchinson and M.B. Pepys W.L. .1984 .C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and. Cardiovascular Disease) Augsburg Cohort Study, 99(2) : 237-242.
Kunutsor S. K.,Seidu S.,Blom A.W.,Khunti K.,Laukkanen J.A. .2017 .Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence. European Journal of Epidemiology, 32(8) : 657-667.
Lavallée P. C.,J. Labreuche D.,Faille M.G.,Huisse P.,Nicaise-Roland M.,Dehoux F.,Gongora-Rivera A.,Jaramillo D.,Brenner D.,Deplanque I.F.,Klein P.J.,Touboul E.,Vicaut N.,Ajzenberg N.,LacunarB.I.C.H.A.T. Investigators N. .2013 .Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel disease. Cerebrovascular Diseases, 36(2) : 131-138.
Liu L.,Duan J. A.,Tang Y.,Guo J.,Yang N.,Ma H.,Shi H. .2012 .Taoren-Honghua herb pair and its main components promoting blood circulation through influencing on hemorheology, plasma coagulation and platelet aggregation. Journal of Ethnopharmacology, 139(2) : 381-387.
Lombardo A.,Biasucci L.M.,Lanza G.A.,Coli S.,Silvestri P.,Cianflone D.,Liuzzo G.,Burzotta F.,Crea F.,Maseri A .2004 .Inflammation as a possible link between coronary and carotid plaque instability. Circulation, 109(25) : 3158-3163.
Mahmood A,Anjum S.,Hussain Z. .1998 .C-reactive protein- inflammatory marker in atherosclerotic conditions in ischemic heart disease and ischemic stroke. The Med Intern, 1(7) : 13-15.
Matsuo T.,Ishikawa H.,Tachi H.,Yoshida K.,Teramoto S. .2014 .Development of exudative tuberculosis during treatment for aspiration pneumonia in an elderly post-stroke patient with symptomatic epilepsy. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 51(5) : 460-465.
Meguid N. A.,Samir H.,Anwar M.,Hashish A.,Koura F.,Chirumbolo S.,Hashem S.,El-Bana M.A.,Hashem H.S. .2018 .Altered S100 Calcium-Binding Protein B and Matrix Metallopeptidase 9 as Biomarkers of Mesial Temporal Lobe Epilepsy with Hippocampus Sclerosis. Journal of Molecular Neuroscience : MN, 66(4) : 482-491.
Mommersteeg P.,Bagijn W.,Widdershoven J.,Westerhuis B.,Schoemaker R.G. .2019 .Gender differences in associations of depressive symptoms and anxiety with inflammatory markers in patients with non-obstructive coronary artery disease. Journal of Psychosomatic Research, 125 : 109779.
Musto A. E.,Rosencrans R.F.,Walker C.P.,Bhattacharjee S.,Raulji C.M.,Belayev L.,Fang Z.,Gordon W.C.,Bazan N.G. .2016 .Dysfunctional epileptic neuronal circuits and dysmorphic dendritic spines are mitigated by platelet-activating factor receptor antagonism. Scientific Reports, 6 : 30298.
Nisha Y.,Bobby Z.,Wadwekar V. .2018 .Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid. Seizure, 60 : 57-60.
Oemrawsingh R. M.,Cheng J.M.,K.M. Akkerhuis M.,Degertekin R.J. van Geuns,Daemen J.,Serruys P.W.,Domburg P.W. .2016 .High-sensitivity C-reactive protein predicts 10-year cardiovascular outcome after percutaneous coronary intervention. EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 12(3) : 345-351.
Paramsothy P.,Knopp R.H.,Bertoni A.G.,Blumenthal R.S.,Wasserman B.A.,Tsai M.Y.,Rue T.,Wong N.D.,Heckbert S.R. .2010 .Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis). Journal of the American College of Cardiology, 56(13) : 1034-1041.
Paudel Y. N.,Shaikh M.F.,Shah S.,Kumari Y.,I. Othman Y. .2018 .Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy. European Journal of Pharmacology, 837 : 145-155.
Qiu R.,Gao Y.,Hou D.,Wang Y.,Yu C.,Wang W.,Gao C.,Tong X.,Wu J .2016 .Association between hs-CRP Levels and the Outcomes of Patients with Small-Artery Occlusion. , 8 : 191.
Rashidinejad H.,Rashidinejad A.,Moazenzadeh M.,Azimzadeh B.S.,Afshar R.M.,Shahesmaeili A.,Mirzaeepour F. .2013 .The role of high-sensitivity C-reactive protein for assessing coronary artery disease severity and left ventricular end diastolic pressure in patients with suspected coronary artery disease. Hong Kong Medical Journal = Xianggang yi xue za zhi, 19(4) : 328-333.
Sohail S.,Hussain Z.,Ashraf Z. .2013 .Blood cholesterol and leptin levels in male smoking and non-smoking patients with diabetes mellitus. International Journal of Biology Research, 1(1) : 13-16.
Terrone G.,Frigerio F.,Balosso S.,Ravizza T.,Vezzani A,101(Pt B .2019 .Inflammation and reactive oxygen species in status epilepticus: Biomarkers and implications for therapy. Epilepsy & Behavior : E&B, 106275 : .
Woernle C. M.,Neidert M.C.,Wulf M.A.,Burkhardt J.K.,Grunwald T.,R.L. Bernays. T. .2013 .Excessively elevated C-reactive protein after surgery for temporal lobe epilepsy. Clinical Neurology and Neurosurgery, 115(8) : 1245-1249.
Yang C.,Li X.,Rong J. .2014 .Amygdalin isolated from Semen Persicae (Tao Ren) extracts induces the expression of follistatin in HepG2 and C2C12 cell lines. Chinese Medicine, 9 : 23.
Wada M.,Nagasawa H.,Kurita K.,Koyama S.,Arawaka S.,Kawanami T.,Tajima K.,Daimon M.,Kato T. .2008 .Cerebral small vessel disease and C-reactive protein: results of a cross-sectional study in communitybased Japanese elderly. Journal of the Neurological Sciences, 264(1-2) : 43-49.
Zahir H.,Javaid A.,Rehman R.,Hussain Z. .2014 .Statistical concepts in biology and health sciences. J Ayub Med Coll Abbottabad, 26(1) : 95-7.
Zhong R.,Chen Q.,Li M.,Zhang X.,Lin W. .2019 .Elevated Blood C-Reactive Protein Levels in Patients With Epilepsy: A Systematic Review and Meta-Analysis. Frontiers in Neurology, 10 : 974.
0

Citations

0

Downloads

57

Views